miR-1271 inhibits growth, invasion and epithelial-mesenchymal transition by targeting ZEB1 in ovarian cancer cells

被引:15
作者
Jiao, Yanni [1 ]
Zhu, Guiping [1 ]
Yu, Jiang [1 ]
Li, Ying [1 ]
Wu, Man [2 ]
Zhao, Jing [1 ]
Tian, Xiangwen [1 ]
机构
[1] Shengli Oil Field, Dept Obstet & Gynecol, Cent Hosp, 31 Jinan Rd, Dongying 257000, Peoples R China
[2] Shengli Oil Field, Dept Pediat, Cent Hosp, Dongying 257000, Peoples R China
关键词
miR-1271; proliferation; invasion; epithelial-mesenchymal transition (EMT); ovarian cancer; PROMOTES APOPTOSIS; GASTRIC-CANCER; PROLIFERATION; MIGRATION; MICRORNA-1271; EXPRESSION; TWIST1;
D O I
10.2147/OTT.S219018
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Objective: MicroRNA-1271 (miR-1271) has a role in suppressing cell growth, cell cycle and promoting cell apoptosis in many cancers. This research was to explore the great role of miR-1271 in ovarian cancer (OC). Patients and Methods: RT-qPCR was utilized to evaluate the mRNA levels of miR-1271 and its target gene. The proliferative and invasive abilities were measured using Cell Counting Kit-8 and transwell assays. The overall survival rate of OC patients was assessed by Kaplan-Meier method. Results: miR-1271 was downregulated in OC tissues, and downregulation of miR-1271 predicted a poor outcome of the OC patients. Zinc finger E-box binding homeobox 1 (ZEB1) was a target gene of miR-1271 and its expression was regulated by miR-1271 in OC. The expression of miR-1271 had a negative connection with the expression of ZEB1 in OC tissues. miR-1271 inhibited cell viability and invasion-mediated epithelial-mesenchymal transition in SKOV3 cells. ZEB1 reversed partial roles of miR-1271 on viability and invasion in OC. Conclusion: miR-1271 inhibited cell proliferation and invasion-mediated EMT in OC. The newly identified miR-1271/ZEB1 axis provides novel insight into the pathogenesis of OC.
引用
收藏
页码:6973 / 6980
页数:8
相关论文
共 39 条
[1]  
[Anonymous], 2018, ANTI-CANCER DRUG, DOI [DOI 10.3322/caac.20115, DOI 10.1097/CAD.0000000000000617]
[2]   The biology of ovarian cancer: new opportunities for translation [J].
Bast, Robert C., Jr. ;
Hennessy, Bryan ;
Mills, Gordon B. .
NATURE REVIEWS CANCER, 2009, 9 (06) :415-428
[3]   MicroRNA signatures in human cancers [J].
Calin, George A. ;
Croce, Carlo M. .
NATURE REVIEWS CANCER, 2006, 6 (11) :857-866
[4]   RETRACTED: MicroRNA-1271 functions as a potential tumor suppressor in hepatitis B virus-associated hepatocellular carcinoma through the AMPK signaling pathway by binding to CCNA1 (Retracted Article) [J].
Chen, Yang ;
Zhao, Zhen-Xian ;
Huang, Fei ;
Yuan, Xiao-Wei ;
Deng, Liang ;
Tang, Di .
JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (04) :3555-3569
[5]  
Du HY, 2018, EUR REV MED PHARMACO, V22, P2697, DOI 10.26355/eurrev_201805_14966
[6]   ZEB1 Is a Transcription Factor That Is Prognostic and Predictive in Diffuse Gliomas [J].
Edwards, Lincoln A. ;
Kim, Sungjin ;
Madany, Mecca ;
Nuno, Miriam ;
Thomas, Tom ;
Li, Aiguo ;
Berel, Dror ;
Lee, Bong-Sup ;
Liu, Minzhi ;
Black, Keith L. ;
Fan, Xuemo ;
Zhang, Wei ;
Yu, John S. .
FRONTIERS IN NEUROLOGY, 2019, 9
[7]   miR-205 enhances radiation sensitivity of prostate cancer cells by impairing DNA damage repair through PKCε and ZEB1 inhibition [J].
El Bezawy, Rihan ;
Tinelli, Stella ;
Tortoreto, Monica ;
Doldi, Valentina ;
Zuco, Valentina ;
Folini, Marco ;
Stucchi, Claudio ;
Rancati, Tiziana ;
Valdagni, Riccardo ;
Gandellini, Paolo ;
Zaffaroni, Nadia .
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 38 (1)
[8]   The transcriptional factor ZEB1 represses Syndecan 1 expression in prostate cancer [J].
Farfan, Nancy ;
Ocarez, Nallatt ;
Castellon, Enrique A. ;
Mejia, Nilo ;
Garcia de Herreros, Antonio ;
Contreras, Hector R. .
SCIENTIFIC REPORTS, 2018, 8
[9]  
Garzon R, 2009, ANNU REV MED, V60, P167, DOI [10.1146/annurev.med.59.053006.104707, 10.1146/annurev.pathol.4.110807.092222]
[10]   RETRACTED: MicroRNA-708 inhibits the proliferation and invasion of osteosarcoma cells by directly targeting ZEB1 (Retracted article. See vol. 27, 2023) [J].
He, Jun ;
Xiang, Deng ;
Lin, Yanshui .
MOLECULAR MEDICINE REPORTS, 2019, 19 (05) :3948-3954